SMARCA4 and thoracic cancer: Therefore, in routine pathological diagnosis, immunohistochemical staining for BRG1 and epithelial makers should be performed to diagnose thoracic cancers with solid architecture and/or necrosis and with poorly differentiated and undifferentiated morphology, especially those with rhabdoid morphology.